Livingston Mark S. sold $7K of PGNY
Livingston Mark S. (CHIEF FINANCIAL OFFICER) sold 279 shares of Progyny, Inc. (PGNY) at $26.20 on 2026-06-02 under a Rule 10b5-1 trading plan.
Insider selling under a 10b5-1 plan is typically low-signal for fundamentals, but it can slightly affect near-term sentiment/positioning.
Progyny CFO Livingston Mark sold 279 shares in an open-market transaction under a pre-arranged 10b5-1 plan, disclosed via Form 4.
Likely minimal, with any effect more sentiment-driven than fundamental.
Background
SEC Form 4 reports insider transactions (officers/directors/10% owners). A 10b5-1 plan indicates sales were pre-scheduled to reduce timing-based trading concerns.
Why it matters
This disclosure provides incremental information about insider liquidity, but the article contains no new operational or financial developments for Progyny.
Market relevance
Traders may treat it as low-signal unless paired with other insider activity or fundamental catalysts.
Market effects
No direct sector read-through; this is company-specific insider activity without new business information.
None indicated.
None indicated.
Alternative perspectives
Even 10b5-1 sales can coincide with management views on valuation; monitor for follow-on selling or changes in sale cadence.
Consider whether there are concurrent insider buys/sales in recent filings and whether the sale size is unusual relative to prior Form 4 activity.
Key entities
- issuerProgyny, Inc.
Company whose CFO disclosed an open-market sale of shares under a pre-arranged 10b5-1 plan.
- insiderLivingston Mark S.
Chief Financial Officer who sold 279 shares on June 2, 2026.
